Hyperekplexia (Startle Disease): Symptoms, Genetics & Treatment
Hyperekplexia (formerly "hyperplexia") is a rare genetic disorder characterized by exaggerated startle responses and neonatal hypertonia.
Clinical Features
Classic Triad
- Exaggerated startle: Sudden, brief, generalized stiffening and flexion/extension in response to unexpected tactile, auditory, or visual stimuli.
- Generalized hypertonia: Present from birth, worse when awake, improves with sleep. "Stiff baby" syndrome.
- Nocturnal myoclonus: Jerks during non-REM sleep.
Additional Features
- Apnea episodes triggered by startle (risk of sudden death in infancy).
- Developmental delay (mild, in some).
- Cataracts, umbilical/inguinal hernia, hip dysplasia (in some genetic subtypes).
- Adult-onset: persistent startle, falls, anxiety, social impairment.
Genetics
| Gene | Protein | Inheritance | Frequency |
|---|---|---|---|
| GLRA1 | Glycine receptor α1 subunit | AD (mostly), AR | ~80% of cases |
| GLRB | Glycine receptor β subunit | AR | Rare |
| SLC6A5 | Glycine transporter GlyT2 | AR | ~10–15% |
| GPHN | Gephyrin (scaffolding) | AR | Very rare |
| ARHGEF9 | Collybistin | X-linked | Rare |
All impair glycinergic inhibition in spinal cord/brainstem → disinhibited motor neurons → exaggerated startle.
Diagnosis
- Clinical: Excessive startle + hypertonia from birth.
- Nose tap test: Sustained stiffening without habituation.
- Genetic testing: Confirmatory; guides recurrence risk.
- EEG/EMG: Normal (differentiates from epilepsy).
Treatment
Pharmacologic
- Clonazepam (first-line): Enhances GABAA inhibition; reduces startle and hypertonia. Start low (0.01–0.03 mg/kg/day).
- Alternatives: Valproate, levetiracetam, gabapentin (less evidence).
Non-Pharmacologic
- Vigevano maneuver: Forceful head flexion → activates vestibulospinal inhibition → aborts stiffening spell.
- Physical therapy: Gait training, fall prevention.
- Genetic counseling.
- Avoid startle triggers (loud alarms, sudden touch).
Prognosis
Hypertonia improves in childhood; startle persists lifelong. Normal lifespan with treatment. Early diagnosis prevents infant apnea deaths.
Huna Hypnotherapy - Related Articles
- Nasal Mucus Terminology: Medical vs. Colloquial Terms
- Why Online Hypnosis Is Not Effective: The Need for Direct Engagement
- Antibodies (Immunoglobulins): Structure, Function, and Clinical Role
- Chatur Hing Methi: Health Benefits and Why It Has a Strong Flavor
- Sebum: Skin's Natural Oil for Moisture, Protection, and Antimicrobial Defense
- Hypoactive Delirium: Understanding Apathetic and Quiet Delirium
- Recurrent Staph Infections: Why They Return & How to Prevent
